Abstract: The invention relates to a device for the collection, pre-analytic treatment, transport and grinding of solid samples, comprising a flask (1) having an opening (11) closed by a removable stopper (2), for receiving a solid sample. Said flask contains a pre-analytic medium (4), a plurality of balls (3) consisting of a solid material, and a means for holding the balls in place, that is designed to lose its effect when the flask is mechanically shaken or closed by the stopper, in such a way that, when the flask is mechanically shaken, the impact of the balls causes the grinding of the solid sample and the mixing thereof with the pre-analytic medium.

Abstract: The invention relates to a pharmaceutical composition for treating the human immunodeficiency virus (HIV) in humans, including three or four active principles selected as: a nucleoside reverse transcriptase inhibitor (NARTI) selected from lamivudine and emtricitabine; a nucleoside or nucleotide reverse transcriptase inhibitor (NARTI) selected from didanosine, abacavir and tenofovir; and the combination of ritonavir with a protease inhibitor (PI) selected from lopinavir, fosamprenavir, atazanavir and darunavir; or an non-nucleoside reverse transcriptase inhibitor (NNRTI) selected from efavirenz and etravirine; for daily administration to said human being one to four days per week.

Abstract: The present invention relates to a pharmaceutical composition for treating the human immunodeficiency virus (HIV) in a human being, comprising four active principles selected as being: a non-nucleoside inhibitor of reverse transcriptase (NNRTI) selected from nevirapine, efavirenz and etravirine; a nucleoside inhibitor of reverse transcriptase (NRTI) selected from lamivudine and emtricitabine; and two different nucleoside or nucleotide inhibitors of reverse transcriptase (NRTI) selected from didanosine, abacavir and tenofovir.

Abstract: The inventive system for automatically generating optimizes codes (19) which are operational on a predefined hardware platform (90) comprises at least one processor which is (91) based on code sources (17) provided by users and comprises means (51, 52) for receiving symbolic code sequences or standard sequences (1) representative for the processor (91) behavior in terms of performance for a predetermined application area, means (53), for receiving static parameters (2), means (55) for receiving dynamic parameters (7), an analysing device (10) for defining optimization rules (9) on the basis of performance tests and measures determined on the basis of the standard sequences (1) and the static (2) and dynamic (7) parameters, a device (80) for optimizing and generating the code receiving the standard sequences (1) and the optimization rules (9) for examining the code sources (17) of the users, detecting optimizable loops, decomposing into cores and for assembling and injecting the codes in such a way that the op